Factors associated with shingles and pneumococcal vaccination among older Canadians

Health Rep. 2024 Jan 17;35(1):14-24. doi: 10.25318/82-003-x202400100002-eng.

Abstract

Background: Immunization against vaccine-preventable diseases such as shingles and pneumococcal disease is especially pertinent among older Canadians. However, vaccine uptake remains low.

Data and methods: Data from the Canadian Health Survey on Seniors (CHSS) - 2019/2020 were used to examine receipt of shingles and pneumococcal vaccines among Canadians aged 65 and older living in the community. Multivariable logistic regression was used to identify individual predisposing, enabling and needs-related factors associated with receipt of each type of vaccination. Reasons reported for not getting vaccinated were also examined.

Results: Based on the 2019/2020 CHSS, an estimated 36.3% of Canadians aged 65 and older (2.3 million people) had received the shingles vaccine, while 51.1% (3.1 million) had received the pneumococcal vaccine. Being a woman, having higher socioeconomic status, having had the flu shot and having a regular health care provider were associated with increased odds of vaccination. Being an immigrant, living outside large population centres, and belonging to South Asian or Chinese population groups were associated with lower odds of vaccination. Over one-third of unvaccinated people did not think the shingles vaccine (39.7%) or the pneumococcal vaccine (36.6%) was necessary. Other frequently reported reasons for non-vaccination were not having heard of the vaccine or the doctor not mentioning it; for the shingles vaccine, 12% cited cost as a reason.

Interpretation: Understanding factors associated with uptake of vaccines and reasons for not obtaining them among older Canadians will help to inform policy and programs aimed at preventing the burden of these diseases.

Keywords: Canada; Vaccinations; compliance; coverage; cross-sectional survey; herpes zoster; immunization; pneumonia.

MeSH terms

  • Aged
  • Canada / epidemiology
  • Female
  • Herpes Zoster Vaccine* / administration & dosage
  • Herpes Zoster* / epidemiology
  • Herpes Zoster* / prevention & control
  • Humans
  • Influenza Vaccines / administration & dosage
  • Male
  • North American People*
  • Pneumococcal Vaccines* / administration & dosage
  • Vaccination / statistics & numerical data

Substances

  • Herpes Zoster Vaccine
  • Influenza Vaccines
  • Pneumococcal Vaccines

Supplementary concepts

  • Canadian people